"Patient outcomes data is the most valuable currency in healthcare." A Chicago company decided to act like it.
Somewhere right now, a patient is tapping through a short questionnaire on a phone. How is the knee. How is the pain. Can you climb stairs yet. It takes ninety seconds, it feels like nothing, and it is exactly the thing healthcare has spent decades failing to capture at scale. That ninety seconds is PatientIQ's entire business.
PatientIQ is a healthcare technology company in Chicago that builds the plumbing for patient-reported outcomes - the part of medicine that asks the patient, not just the chart, whether treatment worked. Today the platform runs inside more than 200 healthcare organizations, has gathered outcomes from over 1.4 million patients, and quietly racks up close to six million data points about what actually happens to people after they leave the clinic.
Hospitals track billing codes to the penny. They log every lab value, every scan, every minute of OR time. What they historically did not track, in any usable way, was the one outcome that matters to the person on the table: did the treatment make their life better. That data lived in paper packets, abandoned spreadsheets, and the occasional well-meaning research project that died when its grant ran out.
It is a strange omission for an industry that runs on evidence. Surgeons could tell you the implant brand but not, in aggregate, how their patients felt a year out. The information existed - it was just scattered, manual, and never wired into the systems doctors actually use.
The fix sounds obvious. Collecting outcomes systematically, integrating with the electronic health record, and turning the results into something a clinician can read at the point of care is the kind of obvious that takes a company to build.
Matthew Gitelis started his career as an investment banking analyst at BMO Capital Markets, advising on mergers and capital raises - a job where analytics are simply assumed to exist. In his mid-twenties he left for Rush Medical College, and there he noticed the tools he had taken for granted in finance were nowhere to be found in the field with arguably higher stakes.
So in 2016, while still a medical student conducting outcomes research at Chicago academic medical centers, he founded PatientIQ. The bet was simple, if not easy: bring the rigor of financial analytics to clinical outcomes, and make it so frictionless that hospitals would actually use it instead of admiring it.
It is, admittedly, a familiar startup origin shape: smart person notices broken thing, builds the thing. The difference here is that the broken thing was sitting in plain sight inside every hospital in the country, and almost nobody had made it boring enough to scale.
PatientIQ is a cloud platform that plugs into the electronic health record - including the big ones, Epic and Cerner - so outcomes collection rides inside the workflows clinicians already live in. Patients get white-labeled surveys on any device, with automated reminders doing the nagging so staff do not have to. The result feeds a single system for measuring, analyzing, and benchmarking what happens to patients.
The design choice that matters most is the least flashy one: integration. Plenty of tools can send a survey. Far fewer can put the answer back where a clinician will actually see it, attached to the right patient, without a separate login or a manual export. By riding the EHR instead of competing with it, PatientIQ avoids the quiet death that kills most outcomes programs - the moment busy staff decide the extra system is not worth the effort. Add enterprise-grade security for regulated environments and built-in biostatistics, and the platform becomes less a survey tool and more an instrument layer for clinical evidence.
EHR-integrated patient-reported outcomes at scale, with patient education, satisfaction management, and registry submission built in.
A clinical trial platform with electronic data capture, eConsent, remote monitoring, and built-in biostatistics.
Benchmarking built on PatientIQ's real-world PRO dataset, so a practice can see how it stacks up against the field.
Data and technical expertise to stand up an outcomes program and actually extract value from it.
A company built on measurement should be willing to be measured. PatientIQ's clearest evidence is its own adoption: in roughly two years it went from 29 organizations to more than 200, a curve steep enough that investors noticed.
The $20 million Series B in May 2022 was led by Health Enterprise Partners, a growth equity firm whose backers include some of the largest health systems and health plans in the U.S. - the exact customers PatientIQ wants. August Capital, an early backer, joined the round, bringing total funding to roughly $26 million. Partnerships followed, including one with Aligned Orthopedic Partners to support care across the Washington, DC region.
Orthopedics is a telling beachhead. It is a specialty where outcomes are tangible - can you walk, can you lift, can you sleep without pain - and where surgeons increasingly need to prove value to payers and device partners. That makes it fertile ground for a platform whose whole proposition is turning recovery into evidence. From there the same machinery extends to other service lines, to medical device companies running trials, and to researchers who would rather spend time on questions than on chasing down data.
PatientIQ's mission is to remove the barriers - financial and technological - that keep healthcare organizations from using outcomes data. The phrasing is modest. The implication is not. If collecting and acting on patient outcomes becomes routine rather than heroic, the practice of medicine shifts from "what we did" toward "what worked."
The company calls this data-driven medicine, which is the sort of phrase that gets stitched onto a tote bag. Underneath it is a concrete idea: a collaborative network where organizations contribute to and learn from a shared real-world dataset, so that one hospital's experience can inform another's decisions.
As real-world evidence becomes the language payers, regulators, and device makers all speak, the organizations that can prove their outcomes will have leverage the ones that cannot will not. The boring ninety-second survey turns into a strategic asset. PatientIQ is betting that the company holding the cleanest, largest, EHR-native record of what works is sitting on something genuinely valuable.
Return to that patient, six weeks out, tapping through a questionnaire about a knee. A few years ago that answer would have vanished into a drawer. Now it joins 1.4 million others, gets benchmarked, informs the next surgeon's decision, and helps a hospital prove it earned its outcomes. The ninety seconds did not change. What healthcare does with them did.